Clinical Trials Logo

Incontinence clinical trials

View clinical trials related to Incontinence.

Filter by:

NCT ID: NCT04426682 Completed - Surgery Clinical Trials

Incontinence Surgery and Urodynamics Parameters

Start date: January 1, 2015
Phase:
Study type: Observational

In patients who have previously had incontinence surgery due to stress incontinence (Midurethral slings (tvt, tot, etc.)), the symptoms may return in the following years and the patient can reapply with urinary incontinence. Urodynamic evaluation is important before stress incontinence surgery to confirm clinical diagnosis based on symptoms and findings and to determine the factors that may affect the effectiveness of surgery and the possibility of complications. Urodynamics evaluation is performed in the preoperative period in patients scheduled for incontinence. Urodynamics evaluation is performed again in patients who applied with post-operative recurrence due to surgery failure or different reasons. It is aimed to show whether there is a difference between the urodynamics parameters of these patients who were examined preoperatively and the urodynamics parameters examined in case of postoperative failure. Thus, the primary goal; to show which of these parameters has deterioration or if the surgical method is insufficient if it is within certain limits or urinary incontinence may recur.

NCT ID: NCT04071288 Completed - Incontinence Clinical Trials

Burch Colposuspension and Mid-urethral Sling Operations

Start date: January 1, 2017
Phase:
Study type: Observational [Patient Registry]

Stress urinary incontinence is common in women. the treatment of this condition is surgery. investigators add stress incontinence surgery to patients who undergo total laparoscopic hysterectomy for benign reasons. Depending on the patient's general condition and indications, the operation can be performed by vaginal approach, as well as mid-urethral sling operations and laparoscopic burch colposuspension. The researchers aimed to compare these two types of operations performed on patients. In this way, the superiority and disadvantage of each other in two procedures will be demonstrated.

NCT ID: NCT03945006 Completed - Multiple Sclerosis Clinical Trials

Balance, Trunk Impairment and Fear of Falling in Multiple Sclerosis Patients With Incontinence

Start date: March 25, 2019
Phase:
Study type: Observational

The aim of the present study was to examine balance, trunk impairment, and fear of falling in MS patients with incontinence. Clinical symptoms of the MS patients are heterogenous, and they vary according to the lesion levels and the duration and the type of the disease. In the neurologic group,especially in MS patients, incontinence is observed even at early stages. Pelvic floor muscles contribute to continence by stabilizing the bladder neck and increasing the intraurethral pressure. Furthermore, they mechanically support the spine and the pelvis.This mechanical support is attained through an increase in sacroiliac joint stiffness and intra-abdominal pressure changes, which are important for spinal control. Along with incontinence, this mechanical support deteriorates resulting in some problems. By this way, postural function of pelvic floor muscles may alter in individuals with incontinence, and thus, lumbopelvic stabilization may be negatively affected. In addition, the activity of trunk muscles changes in individuals with incontinence, which may result in spinal movement and affect the posture. Therefore, balance disorders may develop. Postural sways caused by balance disorders and the decrease in postural corrections have been listed among risk the factors associated with falling. When literature is examined, there exists no study examining the effects of incontinence on balance, trunk impairment, and fear of falling in MS patients. For all these reasons, investigators think that incontinence in MS patients has an effect on balance, trunk impairment, and fear of fall.

NCT ID: NCT03938844 Completed - Incontinence Clinical Trials

BURCH Colposuspension or Transobturatuar Tape (TOT)

Start date: January 1, 2014
Phase:
Study type: Observational

Stress urinary incontinence surgery combined with hysterectomy can often be applied to patients in the same session. The aim of this study was to determine which urinary incontinence surgery would be a better option for patients who would have hysterectomy. The aim of this study was to retrospectively review the data of 69 patients between the ages of 2014 and 2017 who underwent total laparoscopic hysterectomy and anti-incontinence surgery (TOT and Burch) for benign indications (uterine pathology) and stress urinary incontinence (SUI). In addition to demographic data and preoperative examination findings, operative times, postoperative hemogram values, postvoiding residual amounts and complications were examined. In addition, FSI test results of women with sexual activity were compared with ICIQ-UI and UDI-6 interrogations related to urinary incontinence.

NCT ID: NCT03898310 Completed - Clinical trials for Urinary Tract Infections

UTI Prophylaxis With Cranberry Extract After Female Incontinence Surgery

Start date: February 5, 2019
Phase: N/A
Study type: Interventional

The risk of urinary tract infection (UTI) following female incontinence surgery ranges between 6-48%. The literature has shown mixed results of the therapeutic efficacy of cranberry extract to prevent UTI in females, with some promising preliminary work in the prevention of UTI's following gynecologic surgery. The researchers will conduct a study of the effect of cranberry extracts on preventing urinary tract infections following mid urethral slings, which are the most common urinary incontinence procedures.

NCT ID: NCT03510052 Completed - Fecal Incontinence Clinical Trials

Diet and Fecal Incontinence in Senior Women

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

Investigators will conduct a single-arm pre-post intervention pilot study in 46 older women with Fecal Incontinence (FI), also known as Accidental Bowel Leakage (ABL). FI symptoms and stool metabolites will be measured at baseline. Intervention with the Diet Modification Program (DMP) will be administered. FI symptoms and stool metabolites will be measured after 6weeks of the intervention.

NCT ID: NCT03147599 Completed - Bladder Cancer Clinical Trials

Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders

Start date: May 15, 2017
Phase: Phase 4
Study type: Interventional

A randomized controlled trial to assess clinically the efficacy of the selective ileum spasmolytic mebeverine on daytime incontinence and nocturnal enuresis of orthotopic w-ileal neobladders and quality of life effect within 1 year post-surgery.

NCT ID: NCT03120689 Completed - Clinical trials for Pelvic Organ Prolapse

VITOM Study: A Randomized, Controlled Trial.

VITOM
Start date: June 2016
Phase: N/A
Study type: Interventional

This is research in which students are queried by questionnaires on their satisfaction with and experience with certain educational practices (use of a camera image projecting during a live surgery) or with pre-recorded video. As data collection only involves survey data collection and satisfaction with an educational experience, and randomization/intervention is only involving use of one type of educational method versus another .

NCT ID: NCT02954042 Completed - Incontinence Clinical Trials

Pelvital Stress Urinary Incontinence Training Device: P-SUIT

Start date: March 10, 2017
Phase: N/A
Study type: Interventional

The purpose of this investigation is to compare the clinical benefits of using the Pelvital product, in comparison to a sham procedure as a noninvasive treatment for female incontinence

NCT ID: NCT02835846 Completed - Overactive Bladder Clinical Trials

Investigation of the Effect of the Female Urinary Microbiome on Incontinence

FUM
Start date: September 2016
Phase: Phase 4
Study type: Interventional

This purpose of this study is to understand the types of bacteria that are in the bladder and vagina in patients with overactive bladder (OAB) symptoms and understand if the types of bacteria change when with the use of estrogen in the vagina. The investigators are also trying to understand how estrogen influences the body's ability to make substances called peptides that can kill bacteria.